TekniPlex Healthcare Targets Pharma Packaging Shift with High-Barrier, Wearable Drug Delivery Tech at CPHI Milan
Event summary
- TekniPlex Healthcare will showcase its Flexapharm® SBC high-barrier film technology at CPHI Milan 2026, offering a PFAS-free alternative to traditional fluoropolymers.
- The company will highlight its ClearCycle+™ stem gaskets, which eliminate talc and silicone surface treatments for cleaner consumer health dispensing systems.
- TekniPlex will present flexible film reservoir technology for wearable liquid drug delivery, designed for sensitive biologics and next-generation on-body devices.
- The company's ophthalmic solutions portfolio will also be featured, integrating advanced materials, precision components, and drug delivery solutions.
The big picture
TekniPlex Healthcare is positioning itself as a key player in the shift away from legacy materials like fluoropolymers and talc, driven by regulatory and customer pressure. The company's focus on high-barrier protection, wearable drug delivery, and ophthalmic innovations aligns with the industry's move towards more sensitive therapies and patient-centric treatment models. With a growing portfolio of advanced materials and drug delivery solutions, TekniPlex aims to support pharmaceutical partners at every stage of the product life cycle.
What we're watching
- Regulatory Compliance
- How TekniPlex's PFAS-free and talc-free materials will help pharmaceutical companies meet evolving regulatory requirements.
- Market Adoption
- The pace at which wearable drug delivery technology gains traction among pharmaceutical and consumer health companies.
- Sustainability Impact
- Whether TekniPlex's high-barrier film technology can significantly reduce the carbon footprint of pharmaceutical packaging.
Related topics